FDA Warning Letter — Elevate

Case 719811 — FEI 3041550128

The FDA took a Warning Letter action against Elevate on Sep 9, 2025 (Reykjavik, Iceland). The action was issued by CDER and concerns drugs products.

Action details

Facility
Elevate
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Reykjavik (Iceland)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.